Skip to Main Content

OAKLAND, Calif. — Electricity is still hot.

The much-hyped field of “electroceuticals” — which involves zapping nerves with tiny electrical pulses to treat disease — got another injection of funds late last month with a $30 million investment round for startup SetPoint Medical.

advertisement

Major medical device companies Medtronic and Boston Scientific kicked in funding, as did several venture funds. Global pharma giant GlaxoSmithKline has also invested in SetPoint.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED